We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Grants Orphan Drug Designation to Sangamo

News   Sep 08, 2016

 
FDA Grants Orphan Drug Designation to Sangamo
 
 
 

RELATED ARTICLES

CRISPR Gene-editing Tool Gets Sharpened

News

Wake Forest Institute for Regenerative Medicine scientists have fine-tuned their delivery system to deliver a DNA editing tool to alter DNA sequences and modify gene function. The improved "hit and run" system works faster and is more efficient.

READ MORE

Novel Gene Therapy Is Successful in Improving Functional Recovery After Stroke

News

In a mouse model of stroke, researchers successfully pioneer a new gene therapy developed to turn glial cells into neurons.

READ MORE

CRISPR-Chip Moves One Step Closer to the Genomics Market

News

Cardea Bio and Nanosens Innovations have announced that they will be joining forces. We recently spoke with Michael Heltzen, Cardea Bio CEO (and Nanosens co-founder) to learn more about the merger.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE